logologo
QuantliQuantli

SEC Filings

AI highlights what actually matters from SEC filings

Filing Type

Time

SEC Filings Search

McKesson Corporation FY2026 (Year Ended March 31, 2026) – Double-Digit Revenue Growth, Strategic M&A, and Planned Separation of Medical-Surgical Business

McKesson Corporation FY2026 (Year Ended March 31, 2026) – Double-Digit Revenue Growth, Strategic M&A, and Planned Separation of Medical-Surgical Business

McKesson delivered 12% revenue growth to $403.4 billion and 49% EPS growth to $38.38, driven by distribution volume expansion, oncology platform acquisitions totaling $3.4 billion, and operational improvement including a $210 million LIFO credit. The company completed the sale of its Norway operations for a $480 million net gain, returned $5.1 billion to shareholders, and announced plans to separate Medical-Surgical Solutions into an independent company with Apollo Funds acquiring a 13% minority stake for $1.25 billion.

Quantli Newsdesk

16 Jun 2026

10-K
MCK

0

0

Daily Analyst Ratings

Track how 1,000 Wall Street analysts rate stocks — updated daily.

See which S&P 500 stocks analysts expect to rise most.

View Top Upside Stocks

Latest News

Jul 17, 2026 · News · Quantli Newsdesk

Meta in talks to lease $10B compute capacity to Anthropic over two years

Jul 17, 2026 · News · Quantli Newsdesk

Apple Overtakes Nvidia as Most Valuable Company Amid AI Strategy Shift

Jul 17, 2026 · News · Quantli Newsdesk

GE Aerospace Lifts Full-Year EPS Guidance 8% After Q2 Beat
View Latest News

Top Gainers

CDNA

CareDx Inc

$40.34

+35.6%

ATAI

AtaiBeckley Inc

$7.15

+33.4%

MAN

ManpowerGroup Inc

$51.65

+32.4%

MAAS

Maase Inc

$20.95

+26.4%

View all

Upcoming IPOs